ALDX
Aldeyra Therapeutics, Inc.
0.9237$
-21.1%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 100.0% | 99.7% | 99.7% | 99.7% | 99.5% | 99.5% | 99.5% | 99.5% | 99.6% | 99.6% | 99.7% | 99.7% | |
| 97.3% | 96.3% | 72.5% | 56.4% | 58.1% | 52.1% | 54.0% | 48.5% | 76.3% | 97.2% | 97.8% | 94.8% | |
| 97.3% | 96.3% | 94.2% | 95.5% | 96.1% | 96.7% | 96.6% | 96.4% | 96.8% | 97.2% | 97.8% | 94.8% | |
| – | – | 35.4% | 31.7% | 34.1% | – | 0.8% | – | – | – | – | – | |
| 16.5% | 19.2% | 19.7% | 22.0% | 27.5% | 32.1% | 31.8% | 34.9% | 36.7% | 38.6% | 36.6% | 20.3% | |
| 14.7% | 15.0% | 15.3% | 21.9% | 14.6% | 17.8% | 15.3% | 34.8% | 36.6% | 38.6% | 36.6% | 20.3% | |
| 9.2% | 10.4% | 10.9% | 12.3% | 0.5% | 0.3% | 0.3% | 18.1% | 19.9% | 21.6% | 23.3% | 0.3% | |
| 0.2% | 0.9% | 0.2% | 0.2% | 0.2% | 0.2% | 0.4% | 1.7% | 0.0% | 0.2% | 0.2% | 0.3% | |
| 1.8% | – | – | – | 12.8% | 14.3% | 16.2% | – | – | – | – | – | |
| 83.5% | 80.8% | 80.3% | 78.0% | 72.5% | 67.9% | 68.2% | 65.1% | 63.3% | 61.4% | 63.4% | 79.7% | |
| -264.5% | -265.8% | -284.7% | -332.6% | -370.2% | -430.3% | -493.6% | -553.0% | -613.7% | -671.6% | -733.1% | -1,036.7% | |
| 40.1% | 39.9% | 42.0% | 47.1% | 50.7% | 56.9% | 64.3% | 70.7% | 77.3% | 83.5% | 90.7% | 126.9% |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.